Abstract:The most appropriate next step in depression treatment after the initial treatment fails is unclear. This study explores the suitability of the Markov decision process for optimizing sequential treatment decisions for depression. We conducted a formal comparison of a Markov decision process approach and mainstream state-transition models as used in health economic decision analysis to clarify differences in the model structure. We performed two reviews: the first to identify existing applications of the Markov decision process in the field of healthcare and the second to identify existing health economic models for depression. We then illustrated the application of a Markov decision process by reformulating an existing health economic model. This provided input for discussing the suitability of a Markov decision process for solving sequential treatment decisions in depression. The Markov decision process and state-transition models differed in terms of flexibility in modeling actions and rewards. In all, 23 applications of a Markov decision process within the context of somatic disease were included, 16 of which concerned sequential treatment decisions. Most existing health economic models relating to depression have a state-transition structure. The example application replicated the health economic model and enabled additional capacity to make dynamic comparisons of more interventions over time than was possible with traditional state-transition models. Markov decision processes have been successfully applied to address sequential treatment-decision problems, although the results have been published mostly in economics journals that are not related to healthcare. One advantage of a Markov decision process compared with state-transition models is that it allows extended action space: the possibility of making dynamic comparisons of different treatments over time. Within the context of depression, although existing state-transition models are too basic to evaluate sequential treatment decisions, the assumptions of a Markov decision process could be satisfied. The Markov decision process could therefore serve as a powerful model for optimizing sequential treatment in depression. This would require a sufficiently elaborate state-transition model at the cohort or patient level.

Application of Markov Process to the Cost-utility Analysis of Medical Intervention Measures

Uncertainty Analysis of Markov Process to the Cost-utility Analysis of Medical Intervention Measures

Application of Bayesian Statistics and Markov Model in Medical Decision

Markov Model and Meta-Heuristics Combined Method for Cost-Effectiveness Analysis

An Introduction to Markov Modelling for Economic Evaluation

A stochastic framework for estimation of summary measures in cost-effectiveness analyses.

A Medical Decision Making Study based on Markov Chain Model

[Applications of Markov Model for Cost-Effectiveness Analysis of Screening in Epidemiology].

Early Assessment of the Likely Cost-Effectiveness of a New Technology: A Markov Model with Probabilistic Sensitivity Analysis of Computer-Assisted Total Knee Replacement

Probabilistic Sensitivity Analysis of Pharmacoeconomics Research Based on Markov Model

Statistical Process Adjustment Technique Based on Markov Chain Monte Carlo Approach

Decision-analytical modelling in health-care economic evaluations

A tutorial on pharmacometric Markov models

Application of Markov Decision Process in Condition Based Maintenance

Test Optimization for Noninfectious Chronic Disease Based on Markov Decision Process

Instance analysis of Markov model for pharmacoeconomics evaluation

A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process

Markov Decision Process Modeling for Multi-stage Optimization of Intervention and Treatment Strategies in Breast Cancer

Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response

Application of multistate modeling to clinical data analysis

A Markov Decision Process Model of Allocating Emergency Medical Resource among Multi-Priority Injuries.